3.0.0 6802 2026-01-15T04:53:18Z 2026-01-15T04:53:18Z House H HR 2023-12-14 118 https://www.congress.gov/bill/118th-congress/house-bill/6802 <pre>[Congressional Record Volume 169, Number 206 (Thursday, December 14, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Ms. CRAIG:H.R. 6802.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3 of the U.S. ConstitutionThe single subject of this legislation is:Securing America's pharmaceutical supply chain[Page H6987]</pre> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-12-15T16:29:08Z Referred To 2023-12-14T14:01:25Z 118 2510 S 2023-07-26 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2023-12-15 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-12-14 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-12-14 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-12-14 Introduced in House IntroReferral 1000 9 Library of Congress C001119 Rep. Craig, Angie [D-MN-2] Angie Craig D MN 2 N V000133 Rep. Van Drew, Jefferson [R-NJ-2] Jefferson Van Drew R NJ 2 2023-12-14 True S001209 Rep. Spanberger, Abigail Davis [D-VA-7] Abigail Spanberger D VA Davis 7 2023-12-14 True N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] Eleanor Norton D DC Holmes 0 2024-03-07 False H001085 Rep. Houlahan, Chrissy [D-PA-6] Chrissy Houlahan D PA 6 2024-03-12 False S001208 Rep. Slotkin, Elissa [D-MI-7] Elissa Slotkin D MI 7 2024-05-06 False S001200 Rep. Soto, Darren [D-FL-9] Darren Soto D FL 9 2024-08-16 False Health Congressional oversight 2024-06-05T20:26:29Z Drug safety, medical device, and laboratory regulation 2024-06-05T20:26:17Z Government information and archives 2024-06-05T20:26:02Z Government studies and investigations 2024-06-05T20:26:34Z Manufacturing 2024-06-05T20:26:24Z Prescription drugs 2024-06-05T20:25:56Z Public contracts and procurement 2024-06-05T20:26:12Z Strategic materials and reserves 2024-06-05T20:26:07Z Health 2024-01-24T16:15:19Z

00 2023-12-14 Introduced in House 2024-10-10T22:07:45Z <p><strong>Rolling Active Pharmaceutical Ingredient and Drug Reserve Act or the RAPID Reserve Act</strong></p><p>This bill requires the Department of Health and Human Services to contract with drug manufacturers to ensure adequate supplies of critical drugs that have vulnerable supply chains. (Under the bill, drugs are considered critical if they are likely to be needed during a public health emergency or if a shortage would pose a significant threat to the health care system or at-risk populations.)</p><p>Contracted drug manufacturers must agree to (1) maintain at least a 6-month reserve of the active ingredient in a critical drug and of the finished product and to regularly replenish these reserves, (2) produce the ingredient and drug in a manner and quantity as specified in the contract, and (3) agree to transfer portions of the reserve, if necessary, to other manufacturers to meet manufacturing needs and allow HHS to control the allocation of reserves in the event of a public health emergency or other threat.</p><p>HHS must publish a list of critical drugs and issue guidance on the criteria for determining this list and awarding contracts. HHS must give preference to domestic manufacturers for contracts.&nbsp;</p><p>In addition, the Government Accountability Office must report on the capacity of domestic manufacturing with respect to critical drugs, including the ability to manufacture different dosage forms and drugs with various characteristics.</p>

Display Title 45 2024-07-24T15:19:37Z Short Title(s) as Introduced 101 2024-05-24T13:34:59Z Introduced in House IH Short Title(s) as Introduced 101 2024-05-24T13:34:59Z Introduced in House IH Official Title as Introduced 6 2024-03-18T22:01:36Z Introduced in House IH Introduced in House 2023-12-14T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr6802ih/xml/BILLS-118hr6802ih.xml 2023-12-15 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.